Chris Bosh explored the possibility of playing during the postseason while on blood thinner medication, according to The Miami Herald.
The report claims the power forward and his camp looked into the the idea of Bosh continuing to take blood thinners, but had a theory that the medication would be out of his bloodstream by game time.
A source said blood tests indicated the medication was out of Bosh’s system after 8 to 12 hours, which would significantly lessen the risk for Bosh playing. Still, the Heat and team doctors refused to sign off on the idea, according to the report.
MORE: Sixers explore trading Okafor, Noel
One of the biggest threats to a player suiting up on blood thinners is bleeding substantially even if all they suffered was a small cut. They could also fall down and start bleeding internally.
Robert Myerburg, a cardiologist at U-Health and an expert on the treatment of athletes, was also against Bosh playing while on the medication.
“I would not use that strategy [that the Bosh camp explored]," Myerburg said, via the Herald. "There’s too much at risk.The drug being out of the system is not what worries me as much as the unprotected time”
The report also says both Bosh and the Heat are hopeful the 11-time All-Star can return to the court next season.